The legacy of Viagra, and its parent company copyright, presents a complex case study for investors. Originally a blockbuster drug, yielding billions in sales , its intellectual property lapse created a wave of lower-priced alternatives , significantly impacting its position . While certain firms may try to capitalize on related treatments , the cu